Taxol News and Research

RSS
Taxol is a drug used to treat breast cancer, ovarian cancer, and AIDS-related Kaposi sarcoma. It is also used together with another drug to treat non-small cell lung cancer. Taxol is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimitotic agent. Also called paclitaxel.
Incorporation of NexACT technology helps reduce dose of Å6 compound for ovarian cancer treatment

Incorporation of NexACT technology helps reduce dose of Å6 compound for ovarian cancer treatment

EpiCept invites stockholders to attend Annual Meeting

EpiCept invites stockholders to attend Annual Meeting

Plexxikon presents promising preclinical data from PLX3397 in vivo cancer studies

Plexxikon presents promising preclinical data from PLX3397 in vivo cancer studies

Cancer Prevention Coalition's statement on new nominated NCI Director

Cancer Prevention Coalition's statement on new nominated NCI Director

Genta commences Phase 2b trial of tesetaxel in patients with advanced gastric cancer

Genta commences Phase 2b trial of tesetaxel in patients with advanced gastric cancer

Bevacizumab/paclitaxel/carboplatin regimen attains gold-standard status for treatment of non-small-cell lung cancer

Bevacizumab/paclitaxel/carboplatin regimen attains gold-standard status for treatment of non-small-cell lung cancer

NexACT technology demonstrates ability to deliver Taxol subcutaneously

NexACT technology demonstrates ability to deliver Taxol subcutaneously

Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets primary endpoint

Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets primary endpoint

Researchers discover microtentacles that play key role in spreading cancer to distant locations in body

Researchers discover microtentacles that play key role in spreading cancer to distant locations in body

Gene research offers new hope for targeted breast cancer treatment

Gene research offers new hope for targeted breast cancer treatment

Kinesin protein motor shuttles cargo within cells and helps cells divide by rocking like a seesaw

Kinesin protein motor shuttles cargo within cells and helps cells divide by rocking like a seesaw

Formatech issued patent covering novel formulation methods to enhance solubility of certain hydrophobic compounds

Formatech issued patent covering novel formulation methods to enhance solubility of certain hydrophobic compounds

Genta commences Phase 2 trial of tesetaxel on first subject

Genta commences Phase 2 trial of tesetaxel on first subject

Proteomics study reveals protein suppression makes cancers more susceptible to chemotherapy

Proteomics study reveals protein suppression makes cancers more susceptible to chemotherapy

NCCN updates the NCCN Clinical Practice Guidelines for Oncology for Ovarian Cancer

NCCN updates the NCCN Clinical Practice Guidelines for Oncology for Ovarian Cancer

NexMed's NexACT technology enhances Taxol's bioavailability through oral administration

NexMed's NexACT technology enhances Taxol's bioavailability through oral administration

FDA issues Fast Track Designation to Sopherion Therapeutics' Myocet

FDA issues Fast Track Designation to Sopherion Therapeutics' Myocet

Phase II clinical trial results of Liposome-Entrapped Paclitaxel announced

Phase II clinical trial results of Liposome-Entrapped Paclitaxel announced

Cromoz's new drug delivery system to reduce amount of drugs used in cancer treatment

Cromoz's new drug delivery system to reduce amount of drugs used in cancer treatment

Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain

Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain